COVID-19 May Cause Severe Illness in Diabetic Patients

Authors

  • Abu Saim Mohammad Saikat Department of Biochemistry and Molecular Biology, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, Bangladesh

DOI:

https://doi.org/10.30577/jba.v3i2.51

Keywords:

COVID-19, diabetes, coronavirus, hyperglycemia, ACE inhibitor

Abstract

COVID-19 pandemic has become the top public health concern worldwide that represents a threat to the life of billions of people globally. Common causes of death of COVID-19 infected individuals are multi-organ failure, pneumonia, and acute respiratory distress syndrome, out of which pneumonia is the most common. COVID-19 patients with diabetes are at high risk for medical complications, which may lead to severe complications, even death.

Downloads

Download data is not yet available.

Author Biography

Abu Saim Mohammad Saikat, Department of Biochemistry and Molecular Biology, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, Bangladesh

 

 

References

Ahirwar AK, Asia P, Sakarde A, Kaim K (2020). “COVID-19 outbreak–

Diabetes aspect and perspective.” Current Medicine Research and Practice. doi:https://doi.org/10.1016/j.cmrp.2020.05.005.

Hill MA, Mantzoros C, Sowers JR (2020). “Commentary: COVID-19 in patients with diabetes.”Metabolism. doi:https://doi.org/10.1016/j.metabol.2020.154217.

Hossain MS, Ferdous S, Siddiqee MH (2020). “Mass panic during Covid-19 outbreak–A perspective from Bangladesh as a high-risk country.” Journal of Biomedical Analytics, 3(2),1–3. doi:https://doi.org/10.30577/jba.v3i2.40.

IEDCR (accessed June 1, 2020). “Institute of Epidemiology Disease Control and Research.” URL https://www.iedcr.gov.bd/.

Klonoff DC, Umpierrez GE (2020). “COVID-19 in patients with diabetes:risk factors that increase morbidity.” Metabolism-Clinical and Experimental. doi:https://doi.org/10.1016/j.metabol.2020.154224.

Kumar A, Arora A, Sharma P, Anikhindi SA, Bansal N, Singla V, Khare S, Srivastava A (2020). “Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis.” Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

doi:https://doi.org/10.1016/j.dsx.2020.04.044.

Kwong KCNK, Mehta PR, Shukla G, Mehta AR (2020). “COVID-19, SARS and MERS: A neurological perspective.” Journal of Clinical Neuroscience. doi:https://doi.org/10.1016/j.jocn.2020.04.124.

Miazgowski T, Bikowska M, Ogonowski J, Taszarek A (2018). “The Impact of Health Locus of Control and Anxiety on Self-Monitored Blood Glucose Concentration in Women with Gestational Diabetes Mellitus.” Journal of Women’s Health, 27(2), 209–215. doi:https://doi.org/10.1089/jwh.2017.6366.

WHO (accessed June 1, 2020). “WHO Coronavirus Disease (COVID-19) Dashboard n.d.” URL https://bit.ly/2XFrMH9.

WHO (accessed May 24, 2020). “WHO Director-General’s remarks at the media briefingon 2019-nCoV on 11 February 2020.” URL https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020.

Zhou J, Tan J (2020). “Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China.” Metabolism-Clinical and Experimental, 107. doi:https://doi.org/10.1016/j.metabol.2020.154216.

Published

2020-06-07

How to Cite

Saikat, A. S. M. (2020). COVID-19 May Cause Severe Illness in Diabetic Patients. Journal of Biomedical Analytics, 3(2), 15-17. https://doi.org/10.30577/jba.v3i2.51